Document is current
Any future updates will be listed below
-
Authors
Stabler, Thomas C.
Hosch, Salome
Nyakarungu, Elizabeth
Giger, Johanna Nouria
Elonga, Monserrat Kobe
Bibang, Rosalia Nzang
Ndong, Victoria Mangue
Mometolo, Ilda Elobe
Bolopa, Alejandro Lopelo
Bedoung, Rosa Maria Oko
Bijeri, Jose Raso
Roka, Esperanza Willy
Nguema, Ana Gertrudis
Ichinda, Victoria Palacios
Bakale, Salvador
Esokolete, Cristina Nka
Rivas, Matilde Riloha
Galick, David S.
Phiri, Wonder Philip
Guerra, Carlos A.
García, Guillermo A.
Montemartini, Luca
Schindler, Tobias
Silva, Joana C.
Daubenberger, Claudia
-
Funding
Funding for this research was provided by:
Bioko Island Malaria Elimination Project
Goverment of Equatorial Guinea
Diaxxo AG
University of Basel
- License Information
-
More Information
Article History
Received: 8 November 2024
Accepted: 15 April 2025
First Online: 7 May 2025
Declarations
:
: Ethics approval for the 2023 MIS was provided by the Equatorial Guinea Ministry of Health and Social Welfare and the ethics committee of the London School of Hygiene and Tropical Medicine (approval number 5556). Written informed consent was sought from each participating adult and on behalf of participating children under 18 years of age.
: Not applicable.
: LM and TS are employed by and shareholders of the ETH Zurich spin-off company, Diaxxo AG, the organization that produces the DiaxxoPCR device. All other authors declare that they have no competing interests.
